We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest Industry Insights
Developing the World's First Single Molecule Protein Sequencer
Industry Insight

Developing the World's First Single Molecule Protein Sequencer

Jagannath Swaminathan is the co-founder of Erisyon and a researcher at the Marcotte Lab at the University of Texas Austin. In this interview, we discuss the concept of next-generation protein sequencing, clinical proteomics and the critical role of protein sequencing in the fight against COVID-19.
Less Time Managing Inventory, More Time at the Bench? Yes Please
Industry Insight

Less Time Managing Inventory, More Time at the Bench? Yes Please

Lab efficiency is critical to speeding up development processes, yet many researchers find they spend more time managing consumables data than working at the bench. Lab informatics is one solution to this problem.
Advancing ALS Research With Omics Analysis Technology
Industry Insight

Advancing ALS Research With Omics Analysis Technology

Clinical trials produce a massive amount of medically relevant and highly sensitive data. Leveraging such data could make a difference to efforts to create more personalized, effective medicines. We talked to Medidata’s Sheila Diamond to find out more.
Going Label-Free: The Future of Metabolomics Imaging
Industry Insight

Going Label-Free: The Future of Metabolomics Imaging

The study of brain tumors using real-time imaging of the brain in live disease models is critical for elucidating disease mechanisms and developing novel treatment strategies. Such research requires full characterization of healthy and disease phenotypes using a multi-omics analysis, as described in this blog.
Exploring the Therapeutic Potential of Psychedelics
Industry Insight

Exploring the Therapeutic Potential of Psychedelics

Technology Networks recently interviewed Ronan Levy, Founder and Executive Chairman of Field Trip Psychedelics, Inc. to find out more about the therapeutic potential of psychedelics and hear about the drugs undergoing clinical investigation.
Drugging the Microbiome To Treat Obesity
Industry Insight

Drugging the Microbiome To Treat Obesity

Technology Networks recently spoke with Paul-Peter Tak, President & CEO, Kintai Therapeutics, to learn more about the anti-obesity agent the company is currently developing.
Releasing the Handbrake on Endogenous Repair – An Alternative Approach to Treating Alzheimer’s Disease?
Industry Insight

Releasing the Handbrake on Endogenous Repair – An Alternative Approach to Treating Alzheimer’s Disease?

Technology Networks recently spoke with Paul Brennan, President and CEO at NervGen Pharma, to gain his insights on why previous attempts to treat Alzheimer's disease have failed, how the novel technology platform NVG-291 works and what promise it holds for AD.
Motion Capture Trends in Biomechanical Science
Industry Insight

Motion Capture Trends in Biomechanical Science

In this article, we discuss current examples of how motion capture technology can be applied across the life sciences industry.
Tackling Immune Dysregulation – A Key Driver of Disease
Industry Insight

Tackling Immune Dysregulation – A Key Driver of Disease

Immune dysregulation plays a central role in many pathologies. We spoke with Dr Fabienne Charrier-Savournin, from Cisbio, to learn more about the mechanisms underpinning immune dysregulation and how this knowledge is applied for therapeutic intervention.
Thermo Fisher Scientific Joins the Pistoia Alliance
Industry Insight

Thermo Fisher Scientific Joins the Pistoia Alliance

Recently, Thermo Fisher Scientific announced its membership of the Pistoia Alliance. At the Lab of the Future Congress 2019, we spoke with members of the Thermo Fisher team to learn more about the goals of joining the alliance, and what innovation means to Thermo Fisher.
Advertisement